Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix.
about
Molecular mechanisms of HPV mediated neoplastic progressionPractical issues related to uterine pathology: in situ and invasive cervical glandular lesions and their benign mimics: emphasis on cytology-histology correlation and interpretive pitfallsPrevalence of HPV 16 and HPV 18 lineages in Galicia, SpainUnique LCR variations among lineages of HPV16, 18 and 45 isolates from women with normal cervical cytology in Ghana.Human papillomavirus type 16 long control region and E6 variants stratified by cervical disease stage.TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix.Screening and detection of human papillomavirus (HPV) high-risk strains HPV16 and HPV18 in saliva samples from subjects under 18 years old in Nevada: a pilot studyAnalysis of mutations in the E6 oncogene of human papillomavirus 16 in cervical cancer isolates from Moroccan women.Association of human papillomavirus 16 E6 variants with cervical carcinoma and precursor lesions in women from Southern MexicoDifferent Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical CancerAgreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimensHPV16 variants distribution in invasive cancers of the cervix, vulva, vagina, penis, and anus.Type-specific human papillomavirus prevalence in cervical intraepithelial neoplasia and cancer in Iran.Differential HPV16 variant distribution in squamous cell carcinoma, adenocarcinoma and adenosquamous cell carcinoma.Genomic differences in the background of different severity in juvenile-onset respiratory papillomatoses associated with human papillomavirus type 11.An Engineered Cell-Instructive Stroma for the Fabrication of a Novel Full Thickness Human Cervix Equivalent In Vitro.HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.Sites of disruption within E1 and E2 genes of HPV16 and association with cervical dysplasia.Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: Implications for screening and vaccination.Molecular variants of human papilloma virus 16 E2, E4, E5, E6 and E7 genes associated with cervical neoplasia in Romanian patients.Prevalence of HPV16 E1-1374^63nt variants in Greek women.Nucleotide polymorphisms of the human papillomavirus 16 E1 gene.Codon 72 polymorphism of p53 and HPV type 16 E6 variants as risk factors for patients with squamous epithelial lesion of the uterine cervix.E6 and E7 variants of human papillomavirus-16 and -52 in Japan, the Philippines, and Vietnam.Intratype variations of HPV 31 and 58 in Italian women with abnormal cervical cytology.Molecular and phylogenetic analysis of the HPV 16 E4 gene in cervical lesions from women in Greece.Type C2 radical hysterectomy may improve outcomes of locally advanced mucinous adenocarcinoma of the uterine cervix.Strong SOD2 expression and HPV-16/18 positivity are independent events in cervical cancer.Distribution of HPV-16 variants among isolates from Paraguayan women with different grades of cervical lesion.
P2860
Q28070323-5A6C52BF-1001-4EC5-9E31-E36D0CCFD124Q28072431-A3B9E0A8-5F94-415D-A6B0-547E3707537CQ28541777-609D60DF-C90B-4709-B072-DFF2672E67BBQ33592615-B92808DF-29A7-4E38-A0B8-0F2F67E223A4Q34116193-CDDA4C3C-E39E-480F-97AC-B4F8320B7FC5Q34239911-96CF87FC-44FD-4602-936F-D3A4E3794E5CQ34454168-967C27E8-92C2-4CFC-8C1D-ACFFA90BF545Q34953460-F54125E2-EF35-410D-96B4-5657E7F98F76Q35154133-BA46E62B-A3D4-48EE-97A6-257F85B6CF8CQ36236454-69103F5A-D294-49AF-B6A2-7767BB6110B7Q36608039-B82BC1FE-CCFC-4F84-83FB-D685FEDDF7B0Q37373121-6C365E8E-4ADC-4E6E-BDE8-3A92802FC083Q38635196-9B45464A-E5C7-437C-A9AE-A73F2F084728Q38967050-3672E1FB-E977-4BD4-982B-04B50B246088Q39155419-6E6D116C-0607-4309-A906-799AF1F8BDF4Q40260706-1515B853-F542-4968-ACA1-F4D17488C90EQ41736026-35AA09FC-0B32-4FF0-A2C3-4C8B0F268F9FQ41749132-148EE1FD-C1C6-4D8B-BFBE-6EDDB82B3B93Q42197971-AFF9AF09-448D-42BE-B9A5-8C036F70BE00Q42198809-91EE2CF4-D4E4-480B-AE90-1ED04FA9D352Q42237614-E59D6CEE-7702-4383-8FA9-38134081E2C4Q42281876-6727BEDB-C48E-4BBD-A82F-386F2B533AB0Q44119126-E2DE1DF7-C5EC-421F-8A69-D59A1A121F7BQ45391153-59EE1661-E468-4017-A655-E90E57B72EDFQ46449495-5624AA59-F5EA-45AA-B24F-770AFE6D67F0Q48048969-93BE1E7B-CCB3-4E26-820E-89E9F19527E3Q48895804-B5108D59-E9E9-4FC2-B7BD-5E6D1DA3316DQ54207281-24F8A722-F736-4978-967F-E5029C1323A3Q54267797-8AB14265-E615-475D-8BC1-3090411A7545
P2860
Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human papillomavirus (HPV) gen ...... cell carcinoma of the cervix.
@en
type
label
Human papillomavirus (HPV) gen ...... cell carcinoma of the cervix.
@en
prefLabel
Human papillomavirus (HPV) gen ...... cell carcinoma of the cervix.
@en
P2093
P1433
P1476
Human papillomavirus (HPV) gen ...... cell carcinoma of the cervix.
@en
P2093
F M Buonaguro
G Benincasa
M L Tornesello
P356
10.1016/J.YGYNO.2010.12.005
P407
P577
2011-01-06T00:00:00Z